- Oral rinse drugs, encompassing therapeutic and antimicrobial mouthwashes, are increasingly integral to oral healthcare regimens in both clinical and at-home settings due to their effectiveness in reducing plaque, controlling halitosis, and managing oral infections and inflammation
- The rising demand for oral rinse drugs is primarily fueled by the growing prevalence of oral diseases, rising awareness of oral hygiene, and increased recommendations by dental professionals for adjunctive use alongside routine brushing and flossing
- North America dominated the oral rinse drugs market with the largest revenue share of 39.2% in 2024, supported by a high incidence of dental disorders, strong consumer spending on oral care products, and robust marketing by pharmaceutical and personal care companies, particularly in the U.S. where prescription-based and OTC therapeutic rinses are widely adopted
- Asia-Pacific is expected to be the fastest growing region in the oral rinse drugs market during the forecast period due to increasing dental awareness, rapid urbanization, and expanding access to oral healthcare in countries such as China and India
- Therapeutic Mouthwash segment dominated the oral rinse drugs market with a market share of 61.8% in 2024, driven by its proven efficacy in treating oral conditions such as gingivitis, plaque, and mouth ulcers, and strong endorsement by dental professionals
